ARS Pharmaceuticals adds Dr. Rajeev Dadoo and Dr. Peter Kolchinsky to Board along with raising $55m Series D funding led by SR One
– USA, CA – ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions potentially leading to anaphylaxis, has closed on a Series D financing of $55 million led by SR One with participation from RA Capital Management, and one other U.S.-based,…